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Introduction
High blood pressure, or hypertension, affects almost 50
million people in the USA, and places them at higher risk
for cardiovascular disease [1,2]. However, this increased
risk from high blood pressure is not limited to those with
hypertension. Extensive data show that increased blood
pressure is related to increased risk for cardiovascular
disease throughout a broad range of both ‘normal’ and
‘hypertensive’ blood pressures [3]. Normal blood pressure
for an adult is 120/80 mmHg; high blood pressure, or
hypertension, is a systolic blood pressure ³140 mmHg
and a diastolic pressure ³90 mmHg. Currently recom-
mended dietary strategies for lowering blood pressure
include achieving caloric balance in order to avoid over-
weight, limiting alcohol intake, lowering salt intake, and
consuming a diet that is high in fruits, vegetables and low-
fat dairy products, and reduced in overall fat content [1].
Of these, the most controversial is the recommendation to
reduce sodium intake to no more than 100 mmol/day
(2400 mg sodium or 6 g salt), particularly when directed
at the general public. Current US intake, not including dis-
cretionary salt added to prepared foods, is appoximately
143 mmol/day sodium, which is equivalent to approxi-
mately 8.25 g salt/day [4].
Current salt recommendations are based on extensive
literature that includes animal research, population-
based epidemiologic data, observational studies, and
clinical trials [5]. Opponents of these recommendations
object most to their use as a broad public health
message. They contend that only a small percentage of
the population is ‘salt sensitive’, and that most individu-
als would not benefit from reducing their salt intake [6].
A few even argue that a reduced salt intake may actually
be detrimental to some individuals [7–9], although the
studies that support this latter claim have either been
based on extremely low levels of sodium intake
(10–20 mmol/day) or have methodologic shortcomings
[10–12]. The opposing viewpoints are summarized in
two recent editorials [6,13].
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intermediate, and lower sodium levels, each for 30 days. The results indicated lower blood pressure
with lower sodium intake for both diet groups. Although some critics would argue otherwise, these
findings provide important new evidence for the value of the DASH diet and sodium reduction in
controlling blood pressure.
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As the discourse has become increasingly polarized, some
have argued that the proponents of current salt recommen-
dations have lost their scientific objectivity [14]. At the same
time, the major trade association for US salt producers has
been an active force in opposing the current guidelines.
Several of the scientists who most actively oppose the
current guidelines are members of its advisory committee.
The recently concluded DASH–Sodium trial used a rigor-
ously controlled design to examine the impact of sodium
reduction on blood pressure in the context of two very dif-
ferent dietary patterns [15]. When the results were first
presented at the Annual Meeting of the American Society
of Hypertension in May 2000, the US National Heart,
Lung, and Blood Institute of the National Institutes of
Health, which funded the trial, stated that these results
provided the definitive answer to the sodium controversy
[16]. The present commentary summarizes the DASH–
Sodium findings, and the reactions to them.
Background
DASH–Sodium built on the results of the previous Dietary
Approaches to Stop Hypertension (DASH) trial [17,18],
which showed that a diet (the DASH diet [19]) rich in fruits,
vegetables, and low-fat dairy foods and reduced in satu-
rated and total fat, when compared with a more typical
American diet, significantly reduced blood pressure. The
typical American diet may be characterized as a diet that is
high in fat and low in fruits and vegetables. Both studies
included adults with above-optimal blood pressure
(120/80–139/89 mmHg) or at the lower range of stage 1
hypertension (140/90–159/95 mmHg). They were con-
ducted as multicenter, controlled feeding trials, in which
participants received all their food from the clinical center,
and weight, physical activity and alcohol consumption were
held constant. The DASH trial also held sodium intake con-
stant at approximately 3000 mg/day dietary sodium, which
is slightly below what Americans typically consume. In the
DASH trial, 49% of participants were women, 60% were
African-American, and 29% had hypertension.
The DASH trial demonstrated that a diet that is rich in
fruits, vegetables, and low-fat dairy products could achieve
clinically important reductions in blood pressure, as com-
pared with a typical American diet. Those with hyperten-
sion had a reduction of 11.4/5.5 mmHg, and those without
hypertension had a reduction of 5.5/3.0 mmHg. These
reductions occurred in the absence of changes in weight
or sodium intake, appeared within 2 weeks of being on the
diet, and persisted for the 8 weeks of feeding.
The DASH–Sodium trial
The DASH–Sodium trial examined the impact of sodium
reduction on blood pressure within the context of a typical
American diet and the DASH diet [20]. The 412 partici-
pants were randomly assigned to one of these two diet
arms, and within each arm consumed three levels of
sodium in random sequence: a ‘higher’ level of
3300 mg/day, which is comparable to current US intake;
an ‘intermediate’ level of 2400 mg/day, which is equivalent
to the upper limit of current US recommendations; and a
‘lower’ level of 1500 mg/day. Each level of sodium was
consumed by each participant for 4 weeks. In the DASH–
Sodium trial, 57% of participants were women, 57% were
African-Americans, and 41% had hypertension.
The results of the DASH–Sodium trial showed that reduc-
ing dietary sodium lowered blood pressure for the partici-
pants on both the typical American diet and the DASH
diet [15]. The lower the sodium intake, the lower the blood
pressure. Although the reductions were greater for those
with hypertension than for those without, they were still
significant in the latter group (Table 1). Sodium-related
declines were greater for those eating the control diet
than the DASH diet, but the lowest blood pressures were
observed among those who ate the DASH diet while con-
suming sodium at the lower level. This combination
reduced blood pressure more than either the DASH diet
or lower sodium intake alone (8.9/4.5 mmHg below the
control diet at the higher sodium level).
The critics say
Does the DASH–Sodium trial provide the definitive answer
to the debate as the National Heart, Lung, and Blood Insti-
tute claims? Not so, say critics. They claim it is not reduced
sodium that lowers blood pressure, but the DASH diet
alone, which contains a ‘typical’ dietary level of sodium
[21,22]. It is better, they argue, to focus national nutrition
policy on correcting the mineral deficiencies that exist and
are worsening in the US diet, without concern for a single
nutrient such as salt [6]. They also cite the DASH–Sodium
results to support their contention that not all subgroups
within the population responded equally, and that for some
subgroups the impact of sodium reduction was negligible
for those who were already eating the DASH diet.
Responding to the critics
Although we agree there is merit to the argument that sus-
ceptibility to sodium probably varies in the population, this
does not mitigate the importance of the recommendations
from a public health perspective. Indeed, the same individ-
uals who raised this criticism enthusiastically support the
DASH diet despite initial reports that showed marked dif-
ferences in its effectiveness between those with and
without hypertension, and between African-Americans and
non-African-Americans; that is, the DASH diet reduced
blood pressure more in the participants with hypertension
than those without, and more for African-Americans than
whites [23]. Moreover, even though the effect of sodium
varied across subgroups, the fact remains that lower
levels of sodium intake resulted in lower blood pressure
for subgroups defined by race, sex, and hypertensionc
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status, including substantial effects in those without clini-
cal hypertension.
Second, critics have raised the very diversity of the
DASH–Sodium population as a limitation of the study,
claiming that it represents an especially salt-sensitive subset
of the population. Again, it is curious that they choose to
overlook this diversity when they cite this same study, and
the DASH Trial before it, as evidence of the merit of the
DASH diet. The fact is that the DASH–Sodium sample was
constructed precisely so that the investigators could make
valid statements about the effects of dietary factors in a
variety of high-risk and low-risk subgroups. Also, even
though the DASH–Sodium results cannot be extrapolated
to individuals with ‘optimal’ (ie below 120/80 mmHg) blood
pressures, they are directly applicable to the approximately
half of the adult US population whose blood pressures are
above this level. Furthermore, it is not unreasonable to
expect that consumption of the DASH diet at reduced
levels of sodium intake may help prevent the development of
the higher blood pressures that are associated with
increased risk of cardiovascular disease. 
Third, although effectively conceding the value of sodium
reduction among participants eating the control diet,
critics have resorted to the argument that sodium intake is
not important because its effect on blood pressure was
greatly reduced among those who ate the DASH diet.
“Just eat the DASH diet and don’t worry about sodium”,
they say. One could just as easily discount the benefits of
the DASH diet because its blood pressure lowering effect
was greatly reduced when participants’ sodium intake was
50 mmol/day. However, as noted above, critics of the salt
findings cite the DASH–Sodium trial as providing reaffir-
mation of the benefit of the DASH diet. In fact, even
though they are not fully additive, the effects of both eating
the DASH diet and reducing sodium were greater than the
effects of either alone.
Finally, the critics note that DASH–Sodium was a short-
term study, which was conducted under artificial condi-
tions. We believe the controlled feeding design used in
the DASH and DASH–Sodium studies was critical in
order to establish without question the benefits from these
interventions, which are achievable given adequate adher-
ence. The challenge now is to determine ways to help the
American public achieve and sustain such adherence.
MacGregor  et al [24] have shown, assuming that adher-
ence can be maintained, that the blood pressure lowering
effects of sodium reduction persist undiminished for as
long as a year.
Food industry co-operation
Ultimately, the US public will find it difficult to make signifi-
cant reductions in their current sodium intake without the
co-operation of the food industry. Approximately 75% of
the sodium that Americans consume comes from salt that
has been added to processed foods [25]. Without a
change in the foods that can be purchased at the grocery
store and in restaurants, the average American consumer
will find it difficult to lower his or her salt intake substan-
tially. Consequently, a strong public health campaign is
needed to help motivate the food industry to provide more
low-sodium alternatives to the foods they produce.
Conclusion
Proven strategies for reducing blood pressure include
increasing physical activity levels, reducing weight, eating
the DASH diet, limiting alcohol, and reducing sodium
intake. These options are all available to anyone who
wishes to lower his or her blood pressure, and adopting
them singly or in combination should reduce the risks of
stroke and heart and kidney diseases. Having several
options available should increase the chance that at least
one, if not several, will be attempted. Each of these proven
strategies requires long-term commitment and significant
lifestyle change to be effective, which may be difficult to
Available online http://cvm.controlled-trials.com/content/2/2/071
Table 1
Effect on systolic and diastolic blood pressure of reducing sodium intake from the ‘higher’ to the ‘lower’ levels in the
DASH–Sodium trial
Effect of diet on blood pressure (mmHg; mean [95% confidence interval])
Blood pressure n (control diet/DASH diet) Participants who ate the control diet Participants who ate the DASH diet
Systolic
Hypertensive 83/85 –8.3 (–10.0 to –6.6) –4.9 (–6.6 to –3.3)
Nonhypertensive 121/123 –5.6 (–7.0 to –4.1) –1.7 (–3.1 to –0.3)
Diastolic
Hypertensive 83/85 –4.4 (–5.5 to –3.3) –2.5 (–3.6 to –1.4)
Nonhypertensive 121/123 –2.8 (–3.8 to –1.9) –1.1 (–2.0 to –0.1)maintain for the typical person. Nonetheless, health care
providers can offer a simple message: eat lots of fruits,
vegetables and low-fat dairy products; reduce calories
from fat to about 28%; and reduce consumption of
sodium. In addition, co-operation from the food industry in
reducing sodium levels in processed foods is crucial for
the population to make meaningful reductions in their
sodium intake.
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